Shares of Venus Remedies were trading 5% higher on 19 June after the Pan American Health Organization (PAHO) issued a sizable oncology tender to Venus...
Shares of Venus Remedies reached near their 52-week high price after the fixed-dosage injectable manufacturer announced receiving marketing authorisation for two new drugs in Malta,...
Venus Remedies Ltd, on 1 December, announced that it had received market authorisation for multiple new products in the Philippines and Saudi Arabia. In its...
Shares of Venus Remedies rallied 7% on 26 October after the company announced that it had received approval from the Medicines and Healthcare Regulatory Agency...
Venus Remedies, on 20 September, announced receiving marketing approval from Serbia for its drug that is used in the treatment of cancer. The company said...
Shares of Venus Remedies Limited rose 2% in early trade on February 27 after all the company’s production facilities in Baddi, Himachal Pradesh, received a...